Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Truegliclaz M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Truecure Healthcare Private Limited

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Truegliclaz M 80mg/500mg Tablet

Glimepiride/Metformin 80mg/500mg tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial; abrupt cessation, without consulting your doctor, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive treatment plan that incorporates a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular meals and carry a fast-acting sugar source (e.g., glucose tablets, juice) to counter hypoglycemia. Alcohol consumption increases this risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before starting treatment. Pregnant or lactating women should consult their doctor. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Truegliclaz M 80mg/500mg Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Truegliclaz M 80mg/500mg Tablet

Non-insulin-dependent diabetes

Major Benefits of Truegliclaz M 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Truegliclaz M 80mg/500mg tablets with a meal.

Common Side effects of Truegliclaz M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Truegliclaz M 80mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 80mg/500mg Truegliclaz M tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Truegliclaz M 80mg/500mg Tablet works:

Gliclazide and metformin, combined in Truegliclaz M 80mg/500mg tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Truegliclaz M 80mg/500mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Truegliclaz M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Truegliclaz M 80mg/500mg tablets are likely incompatible. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Truegliclaz M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients exhibiting severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Truegliclaz M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in severe cases.

What if you forget to take Truegliclaz M 80mg/500mg Tablet :

Should you forget a Truegliclaz M 80mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Truegliclaz M 80mg/500mg Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Treatment

FAQs on Truegliclaz M 80mg/500mg Tablet

Truegliclaz M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Truegliclaz M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Truegliclaz M 80mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Truegliclaz M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is less likely in patients without kidney disease, who aren't elderly, and who don't consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Truegliclaz M 80mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with an external vitamin B12 source is recommended by some researchers.
Truegliclaz M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with Truegliclaz M 80mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Truegliclaz M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Truegliclaz M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Truegliclaz M 80mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or use with other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Truegliclaz M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Truegliclaz M 80mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Patients with known allergies to Truegliclaz M 80mg/500mg Tablet components or excipients, or those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining alcohol with Truegliclaz M 80mg/500mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Truegliclaz M 80mg/500mg ...
60
MRP 69
13% off